Abstract

It is well established that the two major phenotypic variants of human bladder cancers, the low-grade non-invasive papillary bladder carcinoma (N-Inv-BC) and the high-grade invasive BC (Inv-BC), have different molecular features. For example, compared to 10% in N-Inv-BC, p53 point mutations are found in 70% of Inv-BC. p63 expression is suppressed in aggressive BC. In contrast, more than 70% of N-Inv-BC have FGFR3 mutations compared to the 10% found in Inv-BC. Using well-established human BC cell lines, we found that while Inv-BC cells have a mutator phenotype, N-Inv-BC cells do not. N-Inv-BC cells are proficient in nucleotide excision repair and base excision repair, whereas Inv-BC are deficient in both, and the expression of several DNA repair genes is suppressed in Inv-BC cells. This study aims to understand the role of p63, mutated p53, DNA repair function and cell mutation susceptibility to BC development. Background

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.